NDC directory

Guaifenesin and Dextromethorphan HBr

INNOVUS PHARMACEUTICALS, INC. · TABLET, EXTENDED RELEASE

57483-114ANDADecreased Respiratory Secretion Viscosity [PE]
Product NDC
57483-114
Generic name
Guaifenesin and Dextromethorphan HBr
Labeler name
INNOVUS PHARMACEUTICALS, INC.
Brand name
Guaifenesin and Dextromethorphan HBr
Finished
true
Listing expiration date
20271231
Marketing category
ANDA
Dosage form
TABLET, EXTENDED RELEASE
SPL ID
376b3f7a-3f5b-4524-aca8-8a62876ec52a
Product type
HUMAN OTC DRUG
Marketing start date
20261027
Product ID
57483-114_376b3f7a-3f5b-4524-aca8-8a62876ec52a
Application number
ANDA206941
Brand name base
Guaifenesin and Dextromethorphan HBr
Active ingredients
  1. Name
    GUAIFENESIN
    Strength
    1200 mg/1
  2. Name
    DEXTROMETHORPHAN HYDROBROMIDE
    Strength
    60 mg/1
Packaging
  1. Package NDC
    57483-114-28
    Description
    4 BLISTER PACK in 1 CARTON (57483-114-28) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
    Marketing start date
    20261027
    Sample
    false
Route
ORAL
Pharm class
Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.